Federated Hermes, Inc. Shattuck Labs, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.42 - $3.16 $86 - $192	61 Added 40.13%	213 $0
Q2 2023 Aug 14, 2023	SELL	$2.52 - $3.66 $609 - $885	-242 Reduced 61.42%	152 $0
Q1 2023 May 08, 2023	SELL	$2.5 - $4.72 $1,820 - $3,436	-728 Reduced 64.88%	394 $1,000
Q4 2022 Feb 13, 2023	BUY	$1.96 - $3.26 $1,444 - $2,402	737 Added 191.43%	1,122 $2,000
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.52 $1,001 - $2,125	385 New	385 $1,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $42.4M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.